For: | Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol 2021; 27(42): 7210-7232 [PMID: PMC8611198 DOI: 10.3748/wjg.v27.i42.7210] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i42/7210.htm |
Number | Citing Articles |
1 |
Wannarat Chanket, Methinee Pipatthana, Apiwat Sangphukieo, Phurt Harnvoravongchai, Surang Chankhamhaengdecha, Tavan Janvilisri, Matthew Phanchana. The complete catalog of antimicrobial resistance secondary active transporters in Clostridioides difficile: evolution and drug resistance perspective. Computational and Structural Biotechnology Journal 2024; 23: 2358 doi: 10.1016/j.csbj.2024.05.027
|
2 |
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, Francesco Marotta. Probiotics as Live Biotherapeutics for Veterinary and Human Health, Volume 2. 2024; : 771 doi: 10.1007/978-3-031-65459-6_36
|
3 |
Matthew Phanchana, Methinee Pipatthana, Tanaporn Phetruen, Pattanai Konpetch, Pattaneeya Prangthip, Phurt Harnvoravongchai, Chanakarn Sripong, Sombat Singhakaew, Sarawut Wongphayak, Surang Chankhamhaengdecha, Tavan Janvilisri. Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficile. Biomedicine & Pharmacotherapy 2024; 180: 117469 doi: 10.1016/j.biopha.2024.117469
|
4 |
Samia S. Alkhalil. In silico interaction of catalytic domain of Clostridioides difficile toxins TcdA and TcdB with some selected compounds from the SuperNatural 3.0 database. Kuwait Journal of Science 2025; 52(1): 100355 doi: 10.1016/j.kjs.2024.100355
|
5 |
Marcos Hernando-Gozalo, Carlos Rescalvo-Casas, Laura Seijas-Pereda, Juan Cuadros-González, Ramón Pérez-Tanoira. Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study. Heliyon 2024; 10(10): e30742 doi: 10.1016/j.heliyon.2024.e30742
|
6 |
Ádám Kerek, Ábel Szabó, Péter Ferenc Dobra, Krisztina Bárdos, László Ózsvári, Péter Fehérvári, Zsófia Bata, Viviána Molnár-Nagy, Ákos Jerzsele. Determining the In Vivo Efficacy of Plant-Based and Probiotic-Based Antibiotic Alternatives against Mixed Infection with Salmonella enterica and Escherichia coli in Domestic Chickens. Veterinary Sciences 2023; 10(12): 706 doi: 10.3390/vetsci10120706
|
7 |
Mohamed Halawa, Maxwell Akantibila, Briana E. Reid, Valerie J. Carabetta. Therapeutic proteins have the potential to become new weapons in the fight against antibiotic resistance. Frontiers in Bacteriology 2023; 2 doi: 10.3389/fbrio.2023.1304444
|
8 |
Wichuda Phothichaisri, Tanaporn Phetruen, Surang Chankhamhaengdecha, Tavan Janvilisri, Puey Ounjai, Robert P. Fagan, Sittinan Chanarat. Bacteriophages. Methods in Molecular Biology 2024; 2738: 245 doi: 10.1007/978-1-0716-3549-0_16
|
9 |
Pooja Chaukimath, Gad Frankel, Sandhya S. Visweswariah. The metabolic impact of bacterial infection in the gut. The FEBS Journal 2023; 290(16): 3928 doi: 10.1111/febs.16562
|
10 |
Mohammad Sholeh, Masoumeh Beig, Ebrahim Kouhsari, Mahdi Rohani, Mohammad Katouli, Farzad Badmasti. Global insights into the genome dynamics of Clostridioides difficile associated with antimicrobial resistance, virulence, and genomic adaptations among clonal lineages. Frontiers in Cellular and Infection Microbiology 2025; 14 doi: 10.3389/fcimb.2024.1493225
|
11 |
Mahdi Asghari Ozma, Manouchehr Fadaee, Hamideh Mahmoodzadeh Hosseini, Mohammad Hossein Ataee, Seyed Ali Mirhosseini. A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial Infections. Probiotics and Antimicrobial Proteins 2024; doi: 10.1007/s12602-024-10406-0
|
12 |
Dorota Wultańska, Michał Piotrowski, Hanna Pituch. Antimicrobial Effects of Some Natural Products on Adhesion and Biofilm Inhibition of Clostridioides difficile. Pharmaceutics 2024; 16(4): 478 doi: 10.3390/pharmaceutics16040478
|